Scholarlink

<p>Although mRNA modifications and translational regulation have been extensively studied in various cancers, the precise regulatory mechanisms governing N<sup>1</sup>-methyladenosine (m¹A)-modified tRNAs in acute myeloid leukemia (AML) remain to be elucidated. Here, we reveal a critical oncogenic role of the m¹A methyltransferase complex TRMT6/TRMT61A in leukemogenesis. We observed that TRMT6/TRMT61A is significantly upregulated in AML and predicts a poor prognosis in patients with AML. Functional assays in vitro and in vivo showed that TRMT6/TRMT61A is crucial for maintaining AML cell proliferation, clonogenic potential, and leukemogenesis, and that this function is dependent on its m¹A methyltransferase activity. Mechanistically, TRMT6/TRMT61A mediates m1A modification of tRNAs, thereby increasing the abundance of specific tRNA subsets and enhancing the codon-frequency-dependent translation of TAB2, a key positive regulator of the NF-κB signaling pathway. In summary, our study elucidates the oncogenic mechanism of the TRMT6/TRMT61A-tRNA m¹A-TAB2 axis in AML, providing potential strategies for targeted therapy.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

TRMT6/61A-mediated tRNA m1A methylation promotes codon-dependent TAB2 translation and drives AML progression

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月13日

查看全文
  • Zhirong Jia,
  • Xiang Wu,
  • Aorong Ouyang,
  • ChengZhang,
  • Ya Liu,
  • Guocai Wu,
  • Zhanghui Chen,
  • Songyu Li

摘要

Although mRNA modifications and translational regulation have been extensively studied in various cancers, the precise regulatory mechanisms governing N1-methyladenosine (m¹A)-modified tRNAs in acute myeloid leukemia (AML) remain to be elucidated. Here, we reveal a critical oncogenic role of the m¹A methyltransferase complex TRMT6/TRMT61A in leukemogenesis. We observed that TRMT6/TRMT61A is significantly upregulated in AML and predicts a poor prognosis in patients with AML. Functional assays in vitro and in vivo showed that TRMT6/TRMT61A is crucial for maintaining AML cell proliferation, clonogenic potential, and leukemogenesis, and that this function is dependent on its m¹A methyltransferase activity. Mechanistically, TRMT6/TRMT61A mediates m1A modification of tRNAs, thereby increasing the abundance of specific tRNA subsets and enhancing the codon-frequency-dependent translation of TAB2, a key positive regulator of the NF-κB signaling pathway. In summary, our study elucidates the oncogenic mechanism of the TRMT6/TRMT61A-tRNA m¹A-TAB2 axis in AML, providing potential strategies for targeted therapy.

Graphical Abstract